No. 标题 发布时间 27 Wellmarker Bio Announces Phase I Clinical Trial Plan at the Korea Bio Investment Conference 2020 2020-12-28 26 Wellmarker Bio, an Outstanding Start-up to Watch in Korea 2020-12-24 25 Wellmarker Bio Attends ‘2020 BIO HEALTH FESTIVAL’ as an Innovative Start-up 2020-12-24 24 Wellmarker Bio Featured as an Innovative Growth Company at the Interview with The Korea Economic Daily 2020-11-30 23 Wellmarker Bio Wins Grand Prize for Two Consecutive Years 2020-10-20 22 Wellmarker Bio and AZothBio Signs Research Collaboration Agreement on Developing New Targeted Anticancer-drug 2020-04-07 21 [Interview(University of Ulsan College of Medicine)]Interview with Professor Dong-Hoon Jin 2020-04-07 20 Wellmarker Bio’s Technology Gets the Limelight at the Nature's BioPharma Dealmakers on Oncology 2020-03-10 19 [Interview(EBD Group)]WMBIO Greatly Accelerates the Development of Predictive Biomarker-based Drug 2020-01-14 18 [Interview(Chosun Ilbo)] Developing First-in-Class Anticancer Drug that Can Foresee the Drug’s Efficacy 2019-12-31 1 2 3
